Physical Therapists in Ogden, IA Accepting Medicare
3 Physical Therapists found. Showing 1 - 3
 One To One Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 758 216th Dr, Ogden, IA 50212 Phone: 515-275-4003 Fax: 515-275-4122 |
Boone Rehabilitation Services P C Physical Therapist Medicare: Medicare Enrolled Practice Location: 245 W Walnut St, Ogden, IA 50212 Phone: 877-424-9321 Fax: 515-275-2534 |
 Mrs. Helen Burk Clark, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 758 216th Dr, Ogden, IA 50212 Phone: 515-275-4003 Fax: 515-275-4122 |
News Archive
New NCCN Imaging AUC released for eight new cancers
The National Comprehensive Cancer Network, a Centers for Medicare & Medicaid Services-approved provider-led entity for imaging appropriate use criteria, continues to build its library of AUC and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types. Launched in June 2016, NCCN Imaging AUC currently are available for 20 cancer types.
Researchers discover a gene family strongly implicated in the development of liver cancer
In a comprehensive analysis of human gene activation data, researchers from the Centenary Institute have discovered that the dipeptidyl peptidase-4 (DPP4) gene family is strongly implicated in the development of human hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
U.N. has 'moral responsibility' to address cholera outbreak in Haiti
Sometimes "[w]hen the international aid community descends on a vulnerable place ... good intentions make a bad situation even worse," a Boston Globe editorial states, adding that is "what happened two years ago, when United Nations peacekeepers arrived in Haiti in the wake of a devastating earthquake, bringing the deadly disease cholera with them."
Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors
Oncolytics Biotech Inc. announced today that a paper entitled "Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice," co-senior authored by Dr. Richard Vile of the Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA, and Dr. Kevin Harrington of the Institute of Cancer Research, London, UK, was published in the online version of the Journal of Clinical Investigation on April 1, 2010.
› Verified 6 days ago